May 11, 2023 / 12:30PM GMT
Operator
Good morning ladies and gentlemen and welcome to Fennec Pharmaceuticals First Quarter 2023 Earnings and Corporate Update Conference call. At this time all participants are in a listen only mode. Later we will conduct a question and answer session. Instructions on how to participate will be given at that time. As a reminder, today's conference call is being recorded.
Now, I would like to turn the conference over to Fennec's Chief Financial Officer, Robert Andrade. Please proceed.
Robert Andrade - Fennec Pharmaceuticals - CFO
Thank you, operator. And good morning everyone. We are delighted that you can join us today for Fennec pharmaceuticals First Quarter 2023 Earnings Conference call. During which, we will review our financial results as well as provide a general business update. Joining me from Fennec this morning is Rostislav Raykov our Chief Executive Officer. Before we begin, I would like to remind you that during this call the company will be making forward-looking statements that are subject to risks and uncertainties that may cause actual results
Q1 2023 Fennec Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot